Dr. Michael Brandon Williams, MD

Dr. Williams practices at Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health.

Dr. Williams' NPI, 1295058394, was assigned on March 4, 2010. Dr. Williams graduated from University of Texas Medical School at San Antonio in 2003. Dr. Williams holds Virginia license 0101249728.

Dr. Williams' primary practice is Sentara Norfolk General Hospital, at 600 Gresham Dr, Norfolk, VA 23507 in Norfolk City. The practice phone is (757) 388-3000.

Dr. Williams' primary practice is Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health. Dr. Williams is also affiliated with Sentara Leigh Hospital. The medical group on file is Urology of Virginia. Dmand AI also links Dr. Williams to 3 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Williams practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Williams' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Williams' licenses on file in 2 states: Virginia and Texas.

CMS data shows 25,137 Medicare services from Dr. Williams across 41 procedure codes in 2024, for 1,348 Medicare patients. Medicare paid $574,976 for them.

CMS counts 1,348 Medicare patients who saw Dr. Williams in 2024. The largest group is 75 to 84, with 590 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Williams' median patient age at 74, with 21% women.

In 2024, Dr. Williams wrote 1,422 Medicare Part D claims for 373 patients. 79% of them were for generic drugs. CMS names the drug for 1,304 of them, across 23 drugs with 11 or more claims each, at $3,015,662 in total drug cost. In 2023, CMS named 922 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Williams for performance year 2024, reported as part of a group. Dr. Williams accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Williams as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Williams, published from 2013 to 2025. 2020 was the busiest year, with 3. Dr. Williams' most frequent co-authors are Timothy J. Bradford, MD, Richard D. David, MD and Lawrence I. Karsh, MD.

Dmand AI links Dr. Williams to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Prostatic Neoplasms and Leukemia, B-Cell. Dendreon sponsors the most, 2. Open Payments lists research payments to Dr. Williams that name 1 trial.

CMS Open Payments shows 543 general payments to Dr. Williams from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Ferring Pharmaceuticals Inc. paid the most, $75,013. It also lists 3 research payments totaling $2,817 from 2023 to 2025, naming 1 clinical trial.

Dr. Williams graduated from University of Texas Medical School at San Antonio in 2003.